A considerable body of evidence indicates that the net tubular reabsorption of sodium may be diminished during extracellular volume expansion, independent of the tubular effects of salt-retaining hormones. Since the report by De Wardener, Mills, Clapham, and Hayter (1) , several other studies employing clearance techniques have demonstrated diminished net tubular reabsorption of sodium during saline loading in the dog (2) (3) (4) (5) . In addition, Dirks, Cirksena, and Berliner have reported recently that fractional reabsorption in the proximal nephron of the dog may be diminished strikingly during saline loading (6) . Thus, natriuresis in response to salt loading could be due largely to diminished tubular reabsorption of sodium unrelated to aldosterone. However, such studies have not revealed mechanisms and pathways whereby expansion of the extracellular volume leads to diminished reabsorption of sodium. We recently suggested that increased renal blood flow, and perhaps increased medullary blood flow specifically, may be one factor that by way of intrarenal mechanisms contributes to diminished reabsorption of sodium during saline loading (5) . Furthermore, natriuresis in the absence of salt loading accompanies increased renal blood flow when local vasodilatation is produced by a variety of agents (7) (8) (9) (10) (11) (12) (13) , and we have observed that the unilateral natriuresis accompanying increased renal blood flow during the renal arterial infusion of acetylcholine is due in part to diminished net tubular reab-sorption of sodium (14) . Leyssac has suggested that angiotensin may depress proximal tubular reabsorption (15) , and it has been demonstrated that under certain conditions angiotensin may produce natriuresis (16) (17) (18) (19) . If the reabsorption of sodium distally to the proximal convolution relates in part in some inverse manner to blood flow, then the vasoconstrictor effects of angiotensin could limit the natriuretic effect that the agent could exert by way of depressing proximal tubular reabsorption. Such a dual effect of angiotensin on tubular reabsorption and renal blood flow could explain the inconsistent effects of the agent on sodium excretion. The present studies were therefore undertaken to examine the combined effects of renal vasodilatation and angiotensin on tubular reabsorption and sodium excretion. By producing unilateral renal vasodilatation it was possible to compare the effects of angiotensin on sodium excretion in two kidneys receiving different blood flows in the same animal. Methods
Twenty-one mongrel dogs of either sex ranging in weight from 19.1 to 26.8 kg were deprived of food and water for 18 hours and anesthetized with pentobarbital. The animals were respired automatically with room air. Each ureter was cannulated through flank incisions, and a 23-gauge needle was inserted in the direction of flow into one renal artery (usually the left) near its origin at the aorta. The techniques used for collecting and handling renal venous blood samples have been described elsewhere (14) . Arterial blood samples were collected, and arterial pressure was measured through a catheter inserted into the aorta through a femoral artery. Approximately 3 hours before experimental collections each animal received an im injection containing 5 U of Pitressin Tannate 1 and 10 ute, respectively. When further periods of stable urine Analytical procedures for inulin, p-aminohippurate, soflow had been collected, the infusion of the pressor agent dium, potassium, and osmolality were the same as emwas discontinued, and approximately 30 minutes was al-ployed previously (14) . Arterial blood pressure was lowed for blood pressure and urine flow to stabilize. recorded by a Sanborn pressure transducer and reThen an intravenous infusion of the alternate pressor corder. Renal plasma flow (RPF) was calculated from agent was begun and adjusted to a rate producing the the clearance of p-aminohippurate (CPAH) and the exsame blood pressure as during the infusion of the first traction ratio for PAH (EPAH) (RPF = CPAH/EPAH). pressor agent. After collections during stable blood "Noncortical" plasma flow (NCPF) was calculated as pressure and urine flow the same procedure was followed the difference between RPF and CPAH (NCPF = RPFto return to the first pressor agent. CPAH). (Tables I and II) angiotensin was infused intravenously during continued infusion of the vasodilator into the renal artery. For reasons to be discussed the effects of the renal arterial infusion of angiotensin were usually indistinguishable from the effects of the systemic infusions, and therefore results of all 16 experiments are discussed together.
When the infusion of angiotensin was begun in the presence of unilateral renal vasodilatation, urine flow from the vasodilated kidney increased within 5 to 20 minutes. An earlier rise occurred in the mean arterial blood pressure, and during stable clearance periods mean arterial pressure was elevated by an average of 31 mm Hg (range, 0 to 61 mm Hg) above the levels present during vasodilatation before the infusion of angiotensin. Angiotensin resulted in an increased excretion of sodium by the vasodilated kidney that averaged 141 uEq per minute greater than the rates during vasodilatation alone (range of increase, 9 to 281 ,uEq per minute). In each experiment angiotensin resulted in decreased CPAH, decreased RPF (Tables I to IV) , and usually increased EPAH (Figure 1 ) in the vasodilated kidney. This reduction of hemodynamics and increased excretion of sodium was associated with unchanged or reduced glomerular filtration (below the level present during the vasodilatation alone) in 10 of the 16 experiments (experiment 2, Table I ; experiments 3, 4, and 8 to 10, Table II; and experiments  11 and 13 to 15, Table III ). Thus, the infusion of angiotensin was accompanied by further increases in sodium excretion by the vasodilated kidney despite a reduction in renal plasma flow and usually a reduction in GFR and filtered sodium. When the infusion of angiotensin was discontinued in the presence of continued renal vasodilatation (experiment 2, Table I Tables I to IV. (experiments 6, 7, and 10, Table II ) small increases in sodium excretion by the control kidney occurred during the systemic infusion of angiotensin. However, in the remaining 13 experiments the excretion of sodium by the control kidney decreased during the infusion of angiotensin at a time when marked natriuresis was present in the vasodilated kidney. Although GFR in control kidneys was usually decreased during the infusion of angiotensin, in 8 of the 16 experiments (experiments 1, 3, 6, 7, 9, and 10, Table II; experiments 15 and  16, Table III ) GFR in control kidneys during the infusion of angiotensin was no more than 1 ml per minute less than in the vasodilated kidney despite the marked differences in sodium excretion.
These relationships between renal hemodynamics and sodium excretion during the major phases of the experiments are summarized in Figure 2 .
Comparison of equipressor infusions of angiotensin and norepinephrine during unilateral renal 7vasodilatation. After collections during the stable phase of unilateral renal vasodilatation, an infusion of angiotensin (5 jug 10 minutes of adjustment to achieve a blood pressure similar to that present during the initial infusion. After collections were made during infusion of the second pressor, the same sequence was followed to return to infusion of the first pressor agent. The infusion of acetylcholine (40 ,ug per minute) was continued uninterrupted into the left renal artery. The results of these 5 studies are summarized in Table IV . Both angiotensin and norepinephrine decreased RPF below the levels present during vasodilatation alone, and both agents produced decreases in CPAH in the control kidney. However, during the infusion of the pressor agents CPAH was greater in the vasodilated kidney then in the control kidney. Norepinephrine resulted in increases in sodium excretion by the vasodilated kidneys and decreases in sodium excretion by control kidneys, responses qualitatively similar to those observed during the infusion of angiotensin. Also, the increased sodium excretion by the vasodilated kidneys during the infusion of norepinephrine was not necessarily associated with increased GFR (experiments 18 and 20, Table  IV ). However, in all but one study (experiment 20) the absolute rate of sodium excretion was greater, and the over-all fractional reabsorption of sodium was less during the infusion of angiotensin than during the infusion of norepinephrine. These small differences between the effects of angiotensin and norepinephrine on sodium excretion and reabsorption did not relate to differences in GFR. Thus, the infusion of equipressor amounts of angiotensin or norepinephrine resulted in qualitatively similar changes in hemodynamics and sodium excretion in the vasodilated kidneys.
Discussion
The present results agree with previous studies indicating that renal vasodilatation per se may increase sodium excretion and decrease the net tubular reabsorption of sodium (8, 14) . In our study unilaterally increased renal plasma flow re-suiting from three different vasodilators was accompanied by decreased tubular reabsorption of sodium. These observations strengthen the concept that it is the vasodilatation which results in diminished reabsorption of sodium and not some more direct effect of the infused agent on tubular transport (14) . We have suggested previously that increased renal medullary blood flow may diminish the absolute reabsorption of sodium by the ascending limb of Henle's loop (4, 5) , and Leyssac has suggested that angiotensin may diminish proximal tubular reabsorption of sodium (15) . Although the effects have not been entirely predictable, angiotensin does produce natriuresis under some conditions (16) (17) (18) (19) . If diminished renal blood flow increased sodium reabsorption in Henle's loop or more distal portions of the nephron, then the vasoconstrictor effects of angiotensin could mask the effects that the agent could have to diminish proximal reabsorption by enhancing sodium reabsorption at a more distal site, and perhaps also by reducing GFR and the filtered load of sodium. If so, then induced renal vasodilatation could minimize the vascular effects of angiotensin and permit the agent to produce natriuresis as the result of diminished proximal reabsorption of sodium. To a large extent the present results are consistent with this view. In the presence of renal vasodilatation the infusion of angiotensin invariably was associated with natriuresis that in some cases was comparable to that associated with saline loading (2, 5) .
This angiotensin-induced natriuresis was accompanied by a reduction in RPF and in most cases by a reduction in GFR. In nonvasodilated control kidneys the infusion of angiotensin usually produced decreased sodium excretion in the presence of lower plasma flows (as judged by the clearance of PAH) than were present simultaneously in the natriuretic vasodilated kidneys. It did not appear likely that vasodilatation permitted the natriuresis during the systemic infusion of angiotensin simply by maintaining a higher GFR and filtered load of sodium, since in 10 experiments GFR in control kidneys undergoing sodium retention was similar to or greater than GFR in the vasodilated natriuretic kidneys. Therefore, it appears that the maintenance of some critical level of blood flow was necessary to demonstrate the natriuretic effect of angiotensin. Even though the clearance of PAH during the infusion of angiotensin was greater in vasodilated than in control kidneys, this measurement, as well as total renal plasma flow and noncortical plasma flow, was reduced below the levels present during vasodilatation alone. Therefore, the additional natriuretic effect of angiotensin cannot be attributed to a further increase in any of these hemodynamic measurements. These observations make it unlikely that increased renal blood per se decreases the reabsorption of sodium as suggested previously (5, 14) .
The present studies do not demonstrate that angiotensin exerts a direct effect to decrease the tubular reabsorption of sodium, and the results are more consistent with the view that it is the pressor effect of angiotensin that diminishes sodium reabsorption. In support of this conclusion are the present observations that angiotensin resulted in natriuresis only when given in pressor amounts, and that both angiotensin and norepinephrine produced qualitatively and quantitatively similar changes in renal hemodynamics and sodium excretion when given in equipressor amounts. However, since each of these pressor agents produced natriuresis only in the presence of induced renal vasodilatation, it is apparent that some critical level of renal blood flow or renal vascular resistance is necessary for the effect of increased arterial pressure to decrease the reabsorption of sodium. Since the natriuretic effect of the pressors was not associated with a further increase in hemodynamics in the vasodilated kidney, the natriuresis appears to be the result of the increased perfusion pressure per se. There is other evidence that increased renal perfusion pressure may increase sodium excretion (20) (21) (22) (23) (24) , and that this effect of pressure is mediated through intrarenal mechanisms (20, 22) . The present studies extend such observations and demonstrate that the natriuretic effect of increased arterial pressure is dependent upon prevention of the intense renal vasoconstriction usually associated with the infusion of angiotensin or norepinephrine, since vasoconstriction was minimized in the vasodilated kidneys.
The mechanism whereby increased renal perfusion pressure could decrease sodium reabsorption is unknown. The dependence of this effect of perfusion pressure on induced renal vasodilatation suggests that transmission of the increased perfu-sion pressure to some sensitive portion of the renal vasculature may be responsible for this natriuretic effect. There is some evidence that proximal tubular reabsorption may relate in some direct manner to tubular distension (25) . If so, then constriction of the lumen of the proximal tubule should decrease the reabsorption of sodium and water at that site. If the increased arterial pressure produced in our studies were transmitted to some extent to the postglomerular capillary, then capillary perfusion pressure would be increased, and as a result the cortical interstitial volume should increase. Such an increased interstitial volume could result in some degree of collapse of the tubule, especially when the flow into the tubule as judged by GFR was unchanged or decreased. The effect of vasodilatation alone to decrease sodium reabsorption could be explained by the same mechanism, since a reduction of precapillary resistance would allow a more complete transmission of the existing perfusion pressure to the capillary circulation. Confirmation or rejection of such a mechanism to account for these hemodynamic effects on sodium reabsorption will be dependent upon direct measurements of changes in interstitial volume, tubular distension, and reabsorption in response to hemodynamic changes such as those produced in the present studies.
It does not appear likely that the natriuresis observed in the present studies was due to some direct synergistic effects of the agents on tubular transport, since similar results were observed with combinations of angiotensin or norepinephrine and acetylcholine, bradykinin, or kallidin. Although the natriuretic effect of angiotensin quantitatively was slightly greater than that observed during equipressor infusions of norepinephrine, the effects of the two agents were qualitatively the same. Therefore, even though angiotensin may have a direct effect to decrease the tubular reabsorption of sodium, the present study does not permit such a conclusion. Laragh and his associates found striking differences in the natriuretic effects of angiotensin and norepinephrine in patients with cirrhosis who exhibited natriuretic responses to infusions of angiotensin (18) , in contrast to the similar effects of the two agents observed in the present study. However, it is possible that subtle differences in the renal vasoconstriction produced by the agents could account for the different responses in the patients studied by these latter authors (18) , and in the present study such a possible difference in the renal vascular effects of the two agents was minimized by the induced renal vasodilatation.
Summary
The combined effects of unilateral renal vasodilatation and angiotensin infusion on renal hemodynamics and sodium excretion and reabsorption were studied in anesthetized hydropenic dogs. Unilateral renal vasodilatation alone with either acetylcholine, bradykinin, or kallidin resulted in an ipsilateral increase in renal plasma flow and an ipsilateral decrease in net tubular reabsorption of sodium. The infusion of angiotensin or norepinephrine in the presence of unilateral renal vasodilatation resulted in a sustained marked increase in sodium excretion and decreased sodium reabsorption by the vasodilated kidney. These changes occurred in association with decreases in glomerular filtration rate, clearance of p-aminohippurate, renal plasma flow, and "noncortical" plasma flow. Sodium excretion usually decreased in control nonvasodilated kidneys during the infusion of angiotensin or norepinephrine, although glomerular filtration rate was often similar in the two kidneys.
The clearance of p-aminohippurate, however, was always distinctly lower in the control nonvasodilated kidney.
These results are consistent with the view that the proper combination of two physiologically important variables, arterial pressure and renal vascular resistance, can effect large changes in the tubular reabsorption of sodium, probably through intrarenal mechanisms. We suggest, therefore, that changes in these two variables may be of major importance in the regulation of sodium excretion.
